New report urges UK policymakers to take urgent action on declining child health
The report includes five recommendations for the government to address these issues
Read Moreby Jen Brogan | Feb 14, 2024 | News | 0
The report includes five recommendations for the government to address these issues
Read Moreby Fleur Jeffries | Jul 22, 2022 | News | 0
The treatment has been developed for people aged six years and over will be available for use across the NHS
Read Moreby John Pinching | Mar 4, 2022 | News | 0
New detailed datasets will more accurately map out the impact of obesity throughout UK
Read Moreby Lucy Parsons | May 13, 2021 | News | 0
New results from a Phase IIIa study demonstrate benefits of drug for people with obesity ‘beyond weight loss’
Read Moreby Lucy Parsons | Apr 22, 2021 | News | 0
Study will include approximately 1,000 people with obesity or overweight with comorbidities
Read Moreby Lucy Parsons | Feb 11, 2021 | News | 0
Participants lost on average 14.9% of their baseline body weight
Read Moreby Lucy Parsons | Dec 18, 2020 | News | 0
Danish pharma is seeking approval for drug as a weight management therapy
Read Moreby Lucy Parsons | Nov 3, 2020 | News | 0
Obesity management treatment recommended following confidential discount
Read Moreby Selina McKee | Sep 9, 2020 | News | 0
The move follows a report which found it is not clear that the current programme will be able to drive the progress needed in the timescale available
Read Moreby Selina McKee | Jul 27, 2020 | News | 0
The move follows research highlighting the negative impact of obesity on COVID-19 survival
Read Moreby Selina McKee | Jun 19, 2020 | News | 0
The firm is ‘encouraged’ by the performance of the drug, both as monotherapy and in combination with semaglutide
Read Moreby Anna Smith | Feb 24, 2020 | News | 0
There are 1,969,610 people registered with a GP who have non-diabetic hyperglycaemia, a condition which puts people at high risk of type II.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479